Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.9230
+0.0130 (1.43%)
At close: Apr 10, 2026

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
106131360145
Market Cap Growth
24.01%-52.87%-3.18%-77.69%-58.70%1.59%
Enterprise Value
117141557123
Last Close Price
0.920.552.274.0924.6060.00
PB Ratio
-1.02-0.61-1.67-2.75-19.887.50
P/TBV Ratio
-----7.51
Debt / Equity Ratio
-0.12-0.12-0.13-0.26-1.360.26
Net Debt / Equity Ratio
-0.11-0.11-0.110.01-0.37-0.88
Net Debt / EBITDA Ratio
-0.12-0.12-0.070.00-0.040.70
Net Debt / FCF Ratio
-0.16-0.16-0.090.00-0.060.64
Quick Ratio
0.010.010.030.170.353.51
Current Ratio
0.030.030.040.240.353.69
Return on Equity (ROE)
-----297.38%-89.25%
Return on Assets (ROA)
-435.92%-435.92%-241.99%-211.70%-82.24%-38.09%
Return on Capital Employed (ROCE)
99.70%99.70%163.60%596.90%7112.30%-106.90%
Earnings Yield
-101.20%-168.91%-89.78%-128.57%-40.51%-16.85%
FCF Yield
--114.30%-70.23%-153.13%-32.29%-18.33%
Buyback Yield / Dilution
-84.58%-84.58%-74.87%-17.99%-0.91%-21.22%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.